Derek Jeter was the Yankees’ leadoff man in 137 of his 155 starts last season, but manager Joe Girardi announced today that Jeter will hit second in the Opening Day lineup, with Brett Gardner replacing him in the leadoff spot.
Anything involving Jeter inevitably leads to big headlines, but ultimately the switch is pretty meaningless. Leadoff hitters end up with slightly more plate appearances than No. 2 hitters, while No. 2 hitters end up with slightly more RBI opportunities than leadoff hitters.
Either way, both spots involve coming to the plate more often than everyone else in the lineup and setting the table for the sluggers. And while Jeter was primarily a leadoff man last season he’s actually hit second far more often throughout his career, logging 56 percent of his total plate appearances in the No. 2 spot. And his numbers are identical, with a .313 batting average and .839 OPS leading off compared to a .314 batting average and .840 OPS hitting second.
To me this move is more about Gardner getting a promotion from the bottom of the lineup to the top of the lineup following a very strong season that included a lofty .383 on-base percentage and 47 steals. If the Yankees feel like he’s capable of repeating those numbers the leadoff spot makes all kinds of sense, and since Jeter has more power than Gardner it’s also natural to bat him second.
One negative aspect of Jeter hitting second is that he’ll get more opportunities to ground into double plays after ranking fifth in the league with 22 last season despite batting at least once per game with no one on base, but Gardner tries so many steals (and is fast enough even when he doesn’t take off for second base) that the impact could be minimal.
Jordan Zimmermann signed with the Tigers on Sunday for five years, $110 million. David Price signed with the Red Sox on Monday for seven years, $217 million.
Two big dominos have fallen in this loaded free agent market for starting pitchers, and another big one is about to go …
FOX Sports’ Ken Rosenthal says a deal for Zack Greinke “could come soon” and it’s currently “Dodgers vs. Giants” at the top of the bidding ladder.
ESPN’s Jerry Crasnick confirms that both the Dodgers and Giants are looking for an answer from Greinke, adding that the 32-year-old right-hander seeks a five- or six-year deal with a greater average annual value (AAV) than what Price just secured from Boston. That number would be $31 million, so we’re talking something close to $32 million through 2020-2021.
Greinke opted out of the remaining three years and $71 million contract with Los Angeles in October after posting a 1.66 ERA and 0.84 WHIP across 222 2/3 regular-season innings in 2015. He finished second to the Cubs’ Jake Arrieta in the National League Cy Young Award balloting.
Multiple reports circulated in the past week that the Red Sox would need to unload the money truck in order to sign David Price. Well, the truck just got unloaded: Pete Abraham of the Boston Globe reports that the Red Sox have signed David Price to a seven-year, $217 million contract.
This is, by far, the largest free agent contract the Red Sox have ever given a pitcher. It beats Max Scherzer‘s seven-year, $210 million deal signed last offseason as the largest ever free agent pitcher contract. Clayton Kershaw‘s contract extension with the Dodgers was for $215 million.
Price went 82-47 with a 3.18 ERA pitching in the AL East while with the Tampa Bay Rays. After being traded to the Tigers just before the 2014 trade deadline he went 13-8 with a 2.90 ERA in 32 starts. He returned to the AL East with the Blue Jays this year, going 9-1 with a 2.30 ERA in 11 starts. He also pitched in the playoffs for the Jays starting three times in four overall appearances.
The Red Sox were in dire need of pitching and they were said to be gunning for Price to fill that need. Target: acquired.
MLB and the MLBPA just released the annual public report from the Joint Drug Prevention and Treatment Program’s Independent Program Administrator. It’s the annual report, mandated by the JDA, which says how many positive drug tests there were, what the drugs were, etc.
The notable numbers, which cover the period starting when the 2014 World Series ended until the 2015 World Series ended:
- Total number of tests administered: 8,158. 6,536 of them were urine tests, 1,622 of them were blood tests for HGH;
- 10 tests resulted in positives which led to discipline: 7 for PEDs, 2 for stimulants, one for DHEA;
- The previous year there were 7,929 total tests with 12 which resulted in discipline;
- There were the same number of Therapeutic Use Exemptions granted this year as last: 113. All but two were for attention deficit disorder. One was for gynecomastia, which is the swelling of the breast tissue in men due to a hormone imbalance, one was for a stress fracture in someone’s elbow.
A use exemption line item which had appeared on the list for the previous several years — hypogonadism — was not there, so congratulations to the anonymous player who was either cured or who retired.
As we always note, the number of players who got exemptions for ADD drugs is a bit higher than the occurrence of ADD in the population at large and, once you eliminate kids from ADHD occurrences, it’s likely considerably higher. But that’s none of my business.
With a week remaining in their exclusive negotiating window to sign Byung-ho Park the Twins have agreed to a deal with the Korean slugger. Ken Rosenthal of FOXSports.com reports that it’s a four-year, $12 million contract, on top of which the Twins will pay Park’s old team a $12.85 million posting fee for those negotiating rights.
Four years and a total commitment of $24.85 million is certainly a sizable investment, but it’s significantly less than most projections had the Twins spending to get Park under contract.
Last offseason the Pirates bid $5 million to negotiate with Korean shortstop Jung Ho Kang and then signed him to a four-year, $11 million deal. His success in MLB raised the level of interest in Park, who posted similarly spectacular numbers in Korean, but in the end the price tag wasn’t significantly higher. Based on reports from Korea, it sounds like the Twins low-balled him in negotiations and Park basically just accepted it because he wants to play in MLB.
Three weeks ago I wrote a lengthy breakdown of how Park could fit into the Twins’ plans when they secured the high bid, but the short version is that he’ll slot into the lineup as the starting designated hitter and look to prove that his exceptional production in Korean can carry over to MLB. Park hit .343 with 53 homers, 146 RBIs, and a 1.150 OPS in 140 games for Nexen this past season and has topped a 1.000 OPS in each of the past three years.